
Researchers say they have identified a biomarker that indicates a more agressive form of prostate cancer.  ". new biomarkers hold promise in strengthening our ability to predict response to treatment.  By identifying the more virulent forms of prostate cancer, we may be able to tailor treatment or develop therapies to target the abnormalities identified," explained Alan Pollack, M.D., Ph.D.  

